Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) announced on 5/8/18 that, following the receipt of minutes from a recent meeting with the U.S. Food and Drug Administration (FDA), the Company has... read more
Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) announced on 5/8/18 that, following the receipt of minutes from a recent meeting with the U.S. Food and Drug Administration (FDA), the Company has... read more
Neon Therapeutics, announced on 5/8/18 that it has treated the first patient in a clinical trial evaluating its proprietary personal neoantigen vaccine, NEO-PV-01, in combination with Merck’s anti... read more
Horizon Pharma plc (Nasdaq:HZNP) announced on 5/8/18 that it has received two Notices of Allowance from the United States Patent and Trademark Office for U.S. patent application numbers 15/457,643... read more
The U.S. Food and Drug Administration announced on 5/7/18 that it has permitted marketing of Hemospray, by Wilson-Cook Medical Inc., a new device used to help control certain types of bleeding in... read more